✦ LIBER ✦

Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP

✍ Scribed by Soranobu Ninomiya; Takeshi Hara; Hisashi Tsurumi; Masato Hoshi; Nobuhiro Kanemura; Naoe Goto; Senji Kasahara; Masahito Shimizu; Hiroyasu Ito; Kuniaki Saito; Yoshinobu Hirose; Tetsuya Yamada; Takeshi Takahashi; Mitsuru Seishima; Tsuyoshi Takami; Hisataka Moriwaki

Publisher: Springer
Year: 2010
Tongue: English
Weight: 352 KB
Volume: 90
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-010-1093-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Limited role of interim PET/CT in patien

Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOP

✍ Changhoon Yoo; Dae Ho Lee; Jeong Eun Kim; Jungmin Jo; Dok Hyun Yoon; Byeong Seok 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 139 KB

Lymphotoxin alfa and receptor-interactin

Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

✍ Yee Soo Chae; Jong Gwang Kim; Sang Kyun Sohn; Joon Ho Moon; Shi Nae Kim; Su Jeon 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 334 KB

Clinical impact of bulky mass in the pat

Clinical impact of bulky mass in the patient with primary extranodal diffuse large B cell lymphoma treated with R-CHOP therapy

✍ Moo-Kon Song; Joo-Seop Chung; Oh Sung-Yong; Gyeong-Won Lee; Seung-Geun Kim; Youn 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 242 KB

Achievement of optimal average relative

Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP

✍ A. Bosly; D. Bron; A. Van Hoof; R. De Bock; Z. Berneman; A. Ferrant; L. Kaufman; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 142 KB

R-CHOP-14 in patients with diffuse large

R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study

✍ Antonio Rueda; Pilar Sabin; Juli Rifá; Marta Llanos; José Gómez-Codina; Francisc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract Several studies have shown that adding rituximab to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) or reducing the interval between chemotherapy cycles from 3 weeks to 2 weeks improves survival in patients with diffuse large B‐cell lymphoma (DLBCL). These studies prompt

The prognostic value of immunohistochemi

The prognostic value of immunohistochemical subtyping in Chinese patients with de novo diffuse large B-cell lymphoma undergoing CHOP or R-CHOP treatment

✍ Zu-Guang Xia; Zi-Zhen Xu; Wei-Li Zhao; Shu-Qing Zhao; Fei Ding; Yu Chen; Qiu-She 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 129 KB